Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia

Donor lymphocyte infusion (DLI) is commonly used to treat leukemia relapse following stem cell transplantation. In florid relapse, however, the efficacy of DLI is limited with substantial risk of severe graft-versus-host disease (GvHD). Here, we develop a novel risk-adapted strategy characterized by...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Rujkijyanont, P, Morris, C, Kang, G, Gan, K, Hartford, C, Triplett, B, Dallas, M, Srinivasan, A, Shook, D, Pillai, A, Pui, C-H, Leung, W
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2013
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3763390/
https://ncbi.nlm.nih.gov/pubmed/23995046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2013.39
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍